论文部分内容阅读
在西方世界,血友病儿童接受充分的治疗后,其生活可接近正常。患儿可早期获得诊断,教育患儿家庭在家中进行预防,必要时在家中作替代治疗。除少数出现抑制物外,很多血友病儿童经治疗后能够上学甚或参加运动,其关节腔内出血缺如或甚少,但治疗费用昂贵。在瑞典,一位血友病儿童所需的预防性因子替代治疗的费用、每年约10万美元。然而,国家对所有血友病儿童提供的预防费用仅占其国家健康预算中的0．2％。
In the western world, children with hemophilia have nearly normal life after receiving adequate treatment. Children can be diagnosed early, educating families with children at home to prevent, if necessary, alternative treatment at home. With the exception of a handful of inhibitors, many children with hemophilia can go to school or even participate in sports after their treatment. There are few or no hemorrhage in the joint cavity, but the cost of treatment is high. In Sweden, the cost of a preventative factor replacement therapy for a child with hemophilia is estimated at about $ 100,000 a year. However, the national cost of prevention for all children with hemophilia is only 0.2% of their national health budget.